Are Off-target Effects of Imatinib the Key to Improving Beta-cell Function in Diabetes?

Overview

Journal Ups J Med Sci

Specialty General Medicine

Date 2022 Oct 3

PMID 36187072

Authors

Nils Welsh

Affiliations

Soon will be listed here.

Abstract

The small tyrosine kinase (TK) inhibitor imatinib mesylate (Gleevec, STI571) protects against both type 1 and type 2 diabetes, but as it inhibits many TKs and other proteins, it is not clear by which mechanisms it acts. This present review will focus on the possibility that imatinib acts, at least in part, by improving beta-cell function and survival via off-target effects on beta-cell signaling/metabolic flow events. Particular attention will be given to the possibility that imatinib and other TK inhibitors function as inhibitors of mitochondrial respiration. A better understanding of how imatinib counteracts diabetes will possibly help to clarify the pathogenic role of beta-cell signaling events and mitochondrial function, and hopefully leading to improved treatment of the disease.

Citing Articles

Immunotherapy in type 1 diabetes: Novel pathway to the future ahead.

Ray S, Palui R World J Diabetes. 2024; 15(10):2022-2035.

PMID: 39493558 PMC: 11525730. DOI: 10.4239/wjd.v15.i10.2022.

References

Breccia M, Muscaritoli M, Cannella L, Stefanizzi C, Frustaci A, Alimena G . Fasting glucose improvement under dasatinib treatment in an accelerated phase chronic myeloid leukemia patient unresponsive to imatinib and nilotinib. Leuk Res. 2008; 32(10):1626-8. DOI: 10.1016/j.leukres.2008.01.015. View

Lassila M, Allen T, Cao Z, Thallas V, Jandeleit-Dahm K, Candido R . Imatinib attenuates diabetes-associated atherosclerosis. Arterioscler Thromb Vasc Biol. 2004; 24(5):935-42. DOI: 10.1161/01.ATV.0000124105.39900.db. View

Rena G, Pearson E, Sakamoto K . Molecular mechanism of action of metformin: old or new insights?. Diabetologia. 2013; 56(9):1898-906. PMC: 3737434. DOI: 10.1007/s00125-013-2991-0. View

Fred R, Kappe C, Ameur A, Cen J, Bergsten P, Ravassard P . Role of the AMP kinase in cytokine-induced human EndoC-βH1 cell death. Mol Cell Endocrinol. 2015; 414:53-63. DOI: 10.1016/j.mce.2015.07.015. View

Tsutsui Y, Deredge D, Wintrode P, Hays F . Imatinib binding to human c-Src is coupled to inter-domain allostery and suggests a novel kinase inhibition strategy. Sci Rep. 2016; 6:30832. PMC: 4969603. DOI: 10.1038/srep30832. View

Xu M, Pirtskhalava T, Farr J, Weigand B, Palmer A, Weivoda M . Senolytics improve physical function and increase lifespan in old age. Nat Med. 2018; 24(8):1246-1256. PMC: 6082705. DOI: 10.1038/s41591-018-0092-9. View

Wang J . The capable ABL: what is its biological function?. Mol Cell Biol. 2014; 34(7):1188-97. PMC: 3993570. DOI: 10.1128/MCB.01454-13. View

Gong J, Costanzo A, Yang H, Melino G, Kaelin Jr W, Levrero M . The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature. 1999; 399(6738):806-9. DOI: 10.1038/21690. View

Bellora F, Dondero A, Corrias M, Casu B, Regis S, Caliendo F . Imatinib and Nilotinib Off-Target Effects on Human NK Cells, Monocytes, and M2 Macrophages. J Immunol. 2017; 199(4):1516-1525. DOI: 10.4049/jimmunol.1601695. View

10.

Xia C, Zhang P, Li S, Yuan L, Xia T, Xie C . C-Abl inhibitor imatinib enhances insulin production by β cells: c-Abl negatively regulates insulin production via interfering with the expression of NKx2.2 and GLUT-2. PLoS One. 2014; 9(5):e97694. PMC: 4023982. DOI: 10.1371/journal.pone.0097694. View

11.

Samaha M, Said E, Salem H . Modulatory role of imatinib mesylate on pancreatic β-cells' secretory functions in an STZ rat model of diabetes mellitus. Chem Biol Interact. 2020; 328:109197. DOI: 10.1016/j.cbi.2020.109197. View

12.

Breccia M, Muscaritoli M, Aversa Z, Mandelli F, Alimena G . Imatinib mesylate may improve fasting blood glucose in diabetic Ph+ chronic myelogenous leukemia patients responsive to treatment. J Clin Oncol. 2004; 22(22):4653-5. DOI: 10.1200/JCO.2004.04.217. View

13.

Gitelman S, Bundy B, Ferrannini E, Lim N, Blanchfield J, DiMeglio L . Imatinib therapy for patients with recent-onset type 1 diabetes: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Diabetes Endocrinol. 2021; 9(8):502-514. PMC: 8494464. DOI: 10.1016/S2213-8587(21)00139-X. View

14.

Louvet C, Szot G, Lang J, Lee M, Martinier N, Bollag G . Tyrosine kinase inhibitors reverse type 1 diabetes in nonobese diabetic mice. Proc Natl Acad Sci U S A. 2008; 105(48):18895-900. PMC: 2596241. DOI: 10.1073/pnas.0810246105. View

15.

Gur S, Kadowitz P, Hellstrom W . A protein tyrosine kinase inhibitor, imatinib mesylate (Gleevec), improves erectile and vascular function secondary to a reduction of hyperglycemia in diabetic rats. J Sex Med. 2010; 7(10):3341-50. DOI: 10.1111/j.1743-6109.2010.01922.x. View

16.

Mokhtari D, Al-Amin A, Turpaev K, Li T, Idevall-Hagren O, Li J . Imatinib mesilate-induced phosphatidylinositol 3-kinase signalling and improved survival in insulin-producing cells: role of Src homology 2-containing inositol 5'-phosphatase interaction with c-Abl. Diabetologia. 2013; 56(6):1327-38. DOI: 10.1007/s00125-013-2868-2. View

17.

Bouitbir J, Alshaikhali A, Panajatovic M, Abegg V, Paech F, Krahenbuhl S . Mitochondrial oxidative stress plays a critical role in the cardiotoxicity of sunitinib: Running title: Sunitinib and oxidative stress in hearts. Toxicology. 2019; 426:152281. DOI: 10.1016/j.tox.2019.152281. View

18.

Alton G, Schwamborn K, Satoh Y, Westwick J . Therapeutic modulation of inflammatory gene transcription by kinase inhibitors. Expert Opin Biol Ther. 2002; 2(6):621-32. DOI: 10.1517/14712598.2.6.621. View

19.

Marselli L, Bugliani M, Suleiman M, Olimpico F, Masini M, Petrini M . β-Cell inflammation in human type 2 diabetes and the role of autophagy. Diabetes Obes Metab. 2013; 15 Suppl 3:130-6. DOI: 10.1111/dom.12152. View

20.

Hagerkvist R, Sandler S, Mokhtari D, Welsh N . Amelioration of diabetes by imatinib mesylate (Gleevec): role of beta-cell NF-kappaB activation and anti-apoptotic preconditioning. FASEB J. 2006; 21(2):618-28. DOI: 10.1096/fj.06-6910com. View